MAXIMUS, INC.

MMS

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Deerfield Management

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Deerfield ManagementNEWFeb 17, 2026

Shares: 16,606Value: $1.4M

# Signal Note: Deerfield Management Initiates MMS Position Deerfield's $1.4M entry into MAXIMUS (a government services contractor, not a pharma company) suggests conviction in MMS's business model amid ongoing federal IT modernization and healthcare administration digitization tailwinds. This positioning likely reflects confidence in margin expansion and cash generation rather than pipeline catalysts, aligning with Deerfield's healthcare multi-strategy mandate that includes non-pure-play exposure.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

RDNT1 fund VTR1 fund PHVS1 fund PMVP1 fund ALHC1 fund ATRC1 fund BCRX1 fund NBIX

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: